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SUMMARY
Understanding the negative regulators of anti-viral immune responses will be critical for 
advancing immune-modulated antiviral strategies. NLRX1, an NLR protein that negatively 
regulates innate immunity, was previously identified in an unbiased siRNA screen as required for 
HIV infection. We find that NLRX1 depletion results in impaired nuclear import of HIV-1 DNA in 
human monocytic cells. Additionally, NLRX1 was observed to reduce type-I interferon (IFN-I) 
and cytokines in response to HIV-1 reverse-transcribed DNA. NLRX1 sequesters the DNA sensing 
adaptor STING from interaction with TANK-binding kinase 1 (TBK1), which is a requisite for 
IFN-1 induction in response to DNA. NLRX1-deficient cells generate an amplified STING-
dependent host response to cytosolic DNA, c-di-GMP, cGAMP, HIV-1 and DNA viruses. 
Accordingly, Nlrx1−/− mice infected with DNA viruses exhibit enhanced innate immunity and 
reduced viral load. Thus, NLRX1 is a negative regulator of the host innate immune response to 
HIV-1 and DNA viruses.
Abstract
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INTRODUCTION
A fundamental question in human immunodeficiency virus 1 (HIV-1) research is: Why is the 
immune system unable to contain the virus. Unlocking this key would provide a significant 
advance in the advancement of immune-modulated HIV antivirals and the direct strategies 
for the development of efficacious vaccines/adjuvants. Human Immunodeficiency Virus 1 
(HIV-1) is known to utilize host-encoded proteins to facilitate its replication. On the other 
hand, innate immune response including type-I interferon production triggered by HIV-1 
infection has been reported to restrict virus replication and promote systematic 
inflammation, although innate immunity can also lead to T cell exhaustion, and CD4 T cell 
depletion (Doyle et al., 2015). It is of great significance to understand the roles of host 
proteins in viral replication and innate immune response induction by HIV-1 infection. One 
approach to advance our knowledge of these complex issues is the use of unbiased screening 
to identify pivotal players in HIV infection (Konig and Stertz, 2015). Previous work from 
one of our groups used unbiased RNAi screening to identify host factors that are important 
during the early step of HIV infection that resulted in the promotion of viral infection 
(Konig et al., 2008). The present work describes the importance of a host protein, NLRX1, 
in promoting HIV infection. Different innate immune sensors and mechanisms have been 
identified for HIV-1 components recognition (Altfeld and Gale, 2015). Recent advances 
show that HIV-1 complementary DNA but not its genomic RNA induces IRF3 activation and 
type-I interferon production dependent on cyclic GAMP synthase (cGAS)-STING pathway 
in human macrophages (Gao et al., 2013). Importantly, the polyglutamine binding protein 1 
(PQBP1) is recently identified as the co-receptor of reverse-transcribed HIV-1 DNA and 
associates with cGAS (Yoh et al., 2015). HIV-1 DNA triggers cGAS to synthesize cyclic 
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GMP-AMP (cGAMP), which is the activator of adaptor protein STING to induce IRF3 and 
NF-κB activation, thereafter innate immune response (Gao et al., 2013).
The nucleotide-binding domain, leucine-rich repeat containing proteins (also known as 
NOD-like receptors, NLRs) represent a large family of innate immune receptors or 
regulators which have been primarily associated with inflammasome function (Guo et al., 
2015). However recently they are shown to play important roles in modulating type-I 
interferon production through different mechanisms (Allen, 2014). For example, NLRX1 
was the first NLR found to attenuate IFN-I signaling (Allen et al., 2011; Moore et al., 2008; 
Xia et al., 2011). NLRC3 has been recently identified as an inhibitor of STING function by 
interfering with STING translocation and STING-TBK1 association (Zhang et al., 2014). 
NLRP4 negatively regulates type-I interferon signaling by promoting TBK1 degradation 
(Cui et al., 2012). Nlrp6 binds viral RNA via RNA helicase Dhx15 and interacts with MAVS 
(mitochondrial anti-viral signaling) to induce type-I/III interferons (Wang et al., 2015). 
Although the role of NLRP3 inflammasome in HIV-infected human monocytes is known to 
trigger IL-1β (Chattergoon et al., 2014; Guo et al., 2014), the role of NLRs in modulating 
HIV-1 induced type-I interferon and HIV-1 infection remains unexplored.
Host factors required for HIV-1 infection were previously screened by an unbiased siRNA 
strategy, and NLRX1 was identified as one of 295 hits, although its significance was not 
highlighted nor studied (Konig et al., 2008). NLRX1 is unique in that it resides in the 
mitochondria and mediates a host of functions, including ROS induction (Abdul-Sater et al., 
2010; Tattoli et al., 2008), attenuation of the RIG-I-MAVS and TRAF-IKK signaling (Allen 
et al., 2011; Moore et al., 2008; Xia et al., 2011), and induction of autophagy (Lei et al., 
2012). However, the mechanism by which NLRX1 promotes HIV-1 infection is completely 
unexplored. In this study, we validated that NLRX1 is required for HIV-1 infection in 
multiple cell types including primary human macrophages and dendritic cells. Strikingly, the 
reduction of HIV-1 infection in NLRX1 depletion cells is due to an impaired nuclear import 
of HIV-1 DNA. Furthermore, we found that NLRX1 promotes HIV-1 infection by 
attenuating reverse transcribed HIV-1 DNA induced type-I interferon, interferon stimulatory 
genes (ISGs) and proinflammatory cytokines. Notably, NLRX1 associates with STING to 
reduce TBK1 activation. We also extended the negative regulatory function of NLRX1 to 
immunity to DNA viruses, such as HSV-1 and vaccinia virus.
RESULTS
NLRX1 Enhances HIV-1 Infection
A recent report showed that expression of the mitochondrial localized NLR, NLRX1, is 
decreased in HIV-1 patient (Nasi et al., 2015). From an unbiased siRNA screening for host 
factors required for HIV-1 infection described previously (Konig et al., 2008), we identified 
NLRX1 as a validated hit (Figure 1A). To test the function of NLRX1 in HIV-1 infection in 
more relevant cell types, an HIV-1 permissive, human macrophages cell line, THP-1, was 
used. NLRX1 was knocked down in THP-1 by two different shRNAs (Figure 1B, left panel). 
Notably, HIV-VSV exhibited reduced infection in THP-1 cells containing shRNA for 
NLRX1 over time, compared to cells containing the scrambled shRNA (Figure 1C, left). 
CRISPR/Cas9 strategy was also used to target NLRX1 by two different single guide-RNAs 
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in THP-1 cells (Figure 1B, right panel). In congruent with the shRNA strategy, THP-1 cells 
with attenuated NLRX1 expression showed reduced HIV-1 infection (Figure 1C, right). In 
addition to measurement of luciferase activity for HIV-1 infection, THP-1 cells with 
attenuated NLRX1 expression displayed a lower level of HIV-1 Gag protein p55 compared 
to control cells (Figure 1D and 1E). Finally, NLRX1 was knocked down in human 
monocytes derived macrophages (MDM) and dendritic cells (MDDC) by two to three 
different siRNAs (Figure S1A and 1B, upper panels). HIV-VSV infection was reduced in 
human MDM and MDDC containing siRNA for NLRX1 from three to four different donors 
(Figure S1A and 1B, lower panels). Data pooled from different donors were shown in Figure 
1F and 1G. Importantly, a CCR5/CXCR4 dual tropic HIV-1 strain R3A also showed reduced 
replication in cells with attenuated NLRX1 expression (Figure 1H and Figure S1C) 
(Meissner et al., 2004). To examine the point at which NLRX1 promoted HIV infection, we 
identified that NLRX1 deficiency reduced nuclear import of HIV-1 DNA as measured by the 
nuclear imported 2-LTR circles, but did not affect early, minus strand transfer and 
intermediate stages of HIV-1 reverse transcription (Figure 1I). Taken together, these data 
indicate that NLRX1 is a host factor that enhances HIV-1 infection by increased HIV-1 DNA 
import, a process that is partly controlled by ISGs (Kane et al., 2013).
Removal of NLRX1 Enhances Innate Immune Response to HIV-1 Infection
It was previously shown that NLRX1 functions as a negative regulator of innate immune 
response by inhibiting interferon and cytokines responses (Allen et al., 2011; Moore et al., 
2008; Xia et al., 2011). Thus, we tested if NLRX1 inhibits HIV-1 triggered innate immune 
response which may account for reduced HIV-1 infection. Upon HIV-VSV infection, THP-1 
cells with attenuated NLRX1 expression produced more IFNB mRNA and IFNβ protein than 
control cells (Figure 2A). MX2, a key ISG which inhibits HIV-1 cDNA nuclear import 
(Kane et al., 2013), was also increased in NLRX1 deficient THP-1 cells, consistent with 
decreased HIV-1 DNA nuclear import in the absence of NLRX1 (Figure 1I). Mouse cells 
can be infected with HIV-VSV to interrogate the relevance of a specific gene. Bone marrow 
derived macrophages (BMDM) from Nlrx1−/− mice showed higher induction of IFNβ, 
proinflammatory cytokine genes Il6 and Rantes, and the interferon stimulated gene 15 
(Isg15) than wildtype control cells (Figure 2B). MEFs from Nlrx1−/− mice and littermate 
WT mice were also subjected to HIV-VSV infection (Gao et al., 2013). Similarly, enhanced 
innate immune response was observed in Nlrx1−/− MEFs over time (Figure 2C). To test 
whether enhanced type I IFN alone caused the difference in HIV-1 infection between WT 
and NLRX1 deficient cells, antibody against the interferon-α/β receptor (IFNAR) was used. 
Anti-IFNAR antibody abolished the difference in HIV-1 infection of WT and NLRX1 
deficient cells (Figure 2D), suggesting that increased IFN production by NLRX1 deficient 
cells accounted for reduced HIV-1 infection. In addition, THP-1 cells with shRNA for 
NLRX1 and scrambled shRNA control were infected with HIV-VSV and cultured in 
transwells to allow the diffusion of soluble products across these wells. As a result the 
secretory products in the media should reach equilibrium in these two wells. In this 
configuration, WT and NLRX1 deficient cells exhibited comparable levels of HIV-1 
infection, suggesting that the difference in diffusible secreted factors from WT and NLRX1 
deficient cells accounted for the difference in HIV-1 infection between these two samples 
(Figure 2E). We next investigated key signaling innate immune pathways upon HIV-1 
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infection. HIV-1 infection is known to cause phosphorylation of TBK1 and IKKε, which 
leads to IRF3 activation (Gao et al., 2013; Yoh et al., 2015). The phosphorylation of TBK1, 
IKKε, and IRF3 was significantly enhanced in THP-1 cells with attenuated NLRX1 
expression relative to control cells upon HIV-VSV infection, and this is followed by 
enhanced STAT1 phosphorylation which is known to be activated by type I IFN (Figure 2F). 
In summary, removal of NLRX1 enhanced anti-HIV-1 innate immune response and 
signaling known to affect IFN and cytokine production and this enhancement accounted for 
reduced HIV-1 infection.
NLRX1 Inhibits HIV-1 reverse transcripts induced innate immune response
Previous reports showed that HIV-1 reverse-transcribed DNA, but not RNA, induces innate 
immune response such as IFN and cytokine responses (Gao et al., 2013; Yan et al., 2010). 
We next tested whether NLRX1 inhibits HIV-1 DNA induced innate immune response. As 
described by the previous papers, an HIV-1 reverse transcriptase inhibitor, nevirapine, and an 
integrase inhibitor, raltegravir, were used to inhibit HIV-VSV infection in MEFs (Figure 
S2A). Nevirapine blocks HIV-1 complementary DNA synthesis while raltegravir blocks 
HIV-1 DNA integration into host genome after HIV-1 complementary DNA synthesis 
(Figure S2B). As previous reported in MEF, nevirapine abrogated IFNβ, Isg15, Il6, and 
Rantes induction upon HIV-VSV infection, but raltegravir had no effect. Interestingly, 
enhanced IFNβ, Isg15, Il6, and Rantes induction from HIV-VSV infected Nlrx1−/− MEFs 
was also abrogated when cells were treated with nevirapine while raltegravir had no effect 
(Figure S2C-S2F). These data indicate that NLRX1 inhibits HIV-1 reverse transcribed DNA 
induced innate immune response to promote HIV-1 infection.
NLRX1 Inhibits STING-Dependent DNA Sensing Pathway
In HIV-1 infected cells, PQBP1/cGAS recognizes HIV-1 DNA and generates cyclic cGAMP 
to activate STING (Gao et al., 2013; Yoh et al., 2015). To investigate the role of NLRX1 in 
STING-dependent innate immune signal transduction, we first examined the impact of 
NLRX1 on STING-induced activation of interferon-stimulated responsive element (ISRE)-
luciferase reporter, which is known to be activated by STING, TBK1, and IRF3 (Ishikawa 
and Barber, 2008; Zhong et al., 2008). NLRX1 dramatically reduced ISRE activation by 
STING, but not downstream molecule TBK1 and IRF3, suggesting that NLRX1 interferes 
with STING function (Figure 3A-3C). Even though we previously found that NLRC3 
inhibited STING signaling (Zhang et al., 2014), this has not been a common feature among 
NLRs as several different NLRs including NLRP3, NLRP11, NLRC5, and NOD2 did not 
reduce STING-induced ISRE activation (Figure 3D). STING can be activated by cytosolic 
DNA and cyclic dinucleotides (Burdette et al., 2011; Ouyang et al., 2012; Sun et al., 2013; 
Wu et al., 2013; Zhang et al., 2013), thus we evaluated the role of NLRX1 in cytosolic DNA 
and cyclic dinucleotides induced innate immune signaling. Upon intracellular delivery of 
interferon stimulatory DNA (ISD) (Stetson and Medzhitov, 2006), cyclic di-GMP (c-di-
GMP), or cGAMP, Nlrx1−/− MEFs exhibited enhanced induction of Ifnb, Il6 and Tnf, when 
compared to control MEFs (Figure 3E-3G). Phosphorylation of TBK1 is required for 
STING-dependent interferon and proinflammatory cytokine production. Consistent with the 
cytokine induction data, cGAMP induced greater phosphorylation of TBK1 with a more 
rapid kinetics in Nlrx1−/− than that in control MEFs (Figure 3H). The effect of NLRX1 was 
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further studied in BMDM and peritoneal macrophage. Intracellular delivery of ISD or 
another commonly used DNA stimulus for STING, VACV 70-mer (Unterholzner et al., 
2010), induced more IFNβ in Nlrx1−/− BMDMs than controls (Figure 3I). cGAMP also 
induced more IFNβ cytokine and Ifna4 mRNA in Nlrx1−/− BMDMs (Figure 3I). Similarly in 
peritoneal macrophages, intracellular ISD, VACV 70-mer, or c-di-GMP induced more IFNβ 
in Nlrx1−/− cells than controls (Figure 3J). Taken together, these data indicate that NLRX1 
attenuates STING-dependent innate signaling pathway.
NLRX1 Associates with STING to Disrupt STING-TBK1 Interaction
To explore the mechanism by which NLRX1 interferes with STING-dependent pathway, we 
tested the interaction of NLRX1 with STING as a mechanism by which NLRX1 inhibited 
STING function. In an overexpression system, bi-directional co-immunoprecipitation with 
anti-FLAG or anti-HA beads was followed by immunoblot to show that FLAG-NLRX1 
associated with HA-STING (Figure 4A, left panel). As a specificity control, NLRX1 did not 
interact with cGAS (Figure S3). Recruitment of TBK1 to STING is a critical step that is 
required for IRF3 activation and the induction of interferon and cytokines. Overexpressed 
FLAG-TBK1 and HASTING also showed interaction as expected (Figure 4A, right panel), 
which made it possible to test if NLRX1 interfered with STING-TBK1 association in a later 
experiment. Since overexpressed protein interaction analysis could produce artifacts, we 
tested the association of endogenous NLRX1 with STING. NLRX1-STING association was 
detected by immunoprecipitation using anti-NLRX1 antibody in THP-1 cells and 
immunoblotting with the reciprocal anti-STING antibody. Association was detected in 
controls cells, but not in cells where NLRX1 was eliminated with sg-NLRX1 (Figure 4B, 
left). Reciprocal immunoprecipitation with anti-STING antibody followed by 
immunoblotting with anti-NLRX1 also confirmed endogenous NLRX1-STING association 
(Figure 4B, right). Endogenous NLRX1-STING association was also detected by 
immunoprecipitation using anti-NLRX1 antibody in MEF (Figure 4C). This NLRX1-STING 
association was increased during HSV-1 infection of THP-1 derived macrophages and 
BMDMs (Figure S4). Furthermore, we also determined that the association between NLRX1 
and STING is direct by reciprocal pull-down assay using recombinant full-length NLRX1 
prepared from insect cells and truncated STING protein (amino acid 139-379 and 139-344) 
used previously (Figure S5A, Figure 4D and 4E) (Zhang et al., 2014). To rule out the 
possibility that NLRX1 associates with STING non-specifically, we showed that 
recombinant ASC prepared similarly to NLRX1 did not interact with recombinant STING 
(Figure S5B). To better understand how NLRX1 interacted with STING, we mapped the 
domains of NLRX1 required for this interaction. The results showed that constructs 
containing NBD alone or NBD in combination with other domains interacted with STING. 
Constructs lacking the X (NBD+LRR) or LRR (X+NBD) domain also interacted with 
STING, while construct encoding LRR alone did not interact, suggesting that NBD is the 
key domain of NLRX1 that associated with STING (Figure 4F). Another approach to 
examine for NLRX1 interaction with STING is by microscopy. The antibody for NLRX1 
was found to be unsuitable for immunofluorescence analysis, thus we overexpressed FLAG-
NLRX1 and HASTING to assess their co-localization. Previous reports showed that NLRX1 
is a mitochondrial membrane protein and STING mainly localizes to the endoplasmic 
reticulum (ER). We re-investigated the localization of NLRX1 and found by proteinase K 
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digestion that NLRX1 showed a protease-sensitivity pattern that is consistent with its 
localization to the mitochondrial outer membrane but not in mitochondrial matrix in 
HEK293T cells (Figure S6). Co-localization of NLRX1 and STING was observed by 
confocal microscopy, which could occur on the mitochondria associated membrane (MAM) 
(Figure 4G). We performed co-immunoprecipitation by using isolated MAMs prepared as 
described and confirmed that NLRX1 and STING interacted within this fraction (Figure S7 
and Figure 4H) (Zhang et al., 2011). Finally, we assessed if NLRX1 could interfere with 
STING-TBK1 interaction by assaying for STING-TBK1 interaction in the presence of 
increasing quantities of NLRX1. Increasing NLRX1 reduced STING-TBK1 association in a 
dose-dependent fashion (Figure 4I). These data suggest that NLRX1 associates with STING 
to disrupt STING-TBK1 interaction, thus providing a mechanism by which NLRX1 inhibits 
STING-dependent DNA sensing.
NLRX1 Deficiency Causes Enhanced Innate Immune Response to DNA Viral Infection
We next investigated the broader role of NLRX1 during DNA viruses infection, we infected 
Nlrx1−/− or WT MEFs with DNA viruses vaccinia virus (VACA) or herpes simplex virus 1 
(HSV-1). Ifnb and various innate immune cytokines were induced 6 hr post infection. VACA 
infection induced more Ifnb mRNA and MCP-1 protein compared to control MEFs (Figure 
5A and 5B). Nlrx1−/− MEFs infected with HSV-1 also produced more Ifnb mRNA and IL-6 
protein, as well as MCP-1 and IP-10 than control MEFs (Figure 5C-5F). Furthermore, the 
extent of TBK1 and NF-κB p65 phosphorylation was higher in Nlrx1−/− than that in control 
MEFs (Figure 5G). More phosphorylation of STAT1, which is activated by IFNβ, was also 
induced in Nlrx1−/− than control MEFs, consistent with the observation that Nlrx1−/− cells 
produced more type I IFN compared to control MEFs. Consistent with enhanced innate 
immune response to HSV-1 infection in Nlrx1−/− cells, Nlrx1−/− BMDM contained less 
HSV-1 genomic DNA than WT cells (Figure 5H). These data suggest that NLRX1 is a 
negative regulator of innate immune signals induced by DNA virus in vitro.
STING Deficiency in THP-1 Abrogates the Enhancement of HIV-1 infection by NLRX1
To demonstrate that the impact of NLRX1 on HIV-1 infection occurred through a STING-
dependent pathway, we generated THP-1 cells with diminished NLRX1 and STING 
expression (Figure 6A). The former was reduced by shRNA while the latter was deleted by 
sgRNA. Compared to control cells, HIV-VSV infection was enhanced by 4.91 and 2.41 fold 
2 days post-infection and 3.93 and 2.12 fold 3 days post-infection in two NLRX1 deficient 
cell lines. In the absence of STING, this enhancement of HIV-1 infection in the absence of 
NLRX1 was attenuated at 2 days post- infection and completely abolished at 3 days post-
infection (Figure 6B). Similarly, knocking down NLRX1 expression by shRNA amplified 
HIV-VSV induced IFNB1 and ISG MX2 mRNA levels compared to control cells (Figure 6C 
and 6D). However, induction of IFNB1 and MX2 mRNA by HIV-VSV infection was 
completely abrogated in the absence of STING, regardless of the presence or absence of 
NLRX1 (Figure 6C and 6D). These data provide direct evidences that NLRX1 enhances 
HIV-1 infection and reduces IFNB1 and MX2 expression by negatively regulating STING-
dependent innate immune response. In the absence of STING, NLRX1 does not exert its 
function.
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NLRX1 Negatively Regulate Host Immunity against HSV-1 Infection in Mice
Next, we evaluated the in vivo role of NLRX1 in host innate immune defense against DNA 
viral infection. Nlrx1−/− or WT mice were infected intraperitoneally with HSV-1, and their 
body weight were monitored. Both WT and Nlrx1−/− mice exhibited a transient body weight 
loss during the first two days after infection and then started to recover at day 3 after 
infection (Figure 7A). WT mice showed a 10% body weight loss at day 2, while Nlrx1−/− 
mice only had a 5% weight loss and this difference was maintained through the monitored 
period. As intraperitoneal delivery of HSV-1 did not cause any mortality, we next infected 
WT and Nlrx1−/− mice with HSV-1 intravenously (Zhang et al., 2014). With a lower dose of 
HSV-1 infection by this route (2×107 PFU/mouse), WT mice showed more body weight loss 
than Nlrx1−/− mice (Figure 7B). At a higher dose of HSV-1 infection (5×107 PFU/mouse), 
40% of WT mice died by day 5 post-infection while only 9% of Nlrx1−/− mice died at this 
time-point (Figure 7C). Consistently, HSV-1 genome copies and live viruses were more than 
a log higher in the brains of WT mice harvested at day 5 after intravenous infection than 
those in Nlrx1−/− mice (Figure 7D and E). Nlrx1−/− mice also displayed a moderate higher 
production of IFNβ and IL-6 in the serum upon HSV-1 infection than WT mice (Figure 7F 
and 7G). Taken together, these data indicate that NLRX1 negatively impacts the ability of 
the host to contain a DNA viral infection.
DISCUSSION
The identification of negative regulators of the adaptive immune system such as PD-1 and 
CTLA-4 has revolutionized therapeutic approaches to manipulate T cell immunity in 
infection and cancer (Pardoll, 2012). By comparison, checkpoints or negative regulators of 
innate immunity have been limited. This is a particularly critical issue in HIV research, since 
the host immunity is ineffective in eliminating the virus. Previous work has shown that 
HIV-1 exploits the exonuclease TREX1 to degrade viral DNA and subvert its sensing by 
host cells (Yan et al., 2010). In this study, we show that NLRX1 serves as a negative 
regulator of innate immunity resulting in the promotion of HIV-1 infection. Recent findings 
have demonstrated that reverse transcribed HIV-1 DNA induces type-I interferon and pro-
inflammatory cytokines through initiation of the PQBP1/cGAS innate response pathway. 
Our study shows that NLRX1 inhibits IFN induced by antagonizing this pathway. This is 
achieved by the association of NLRX1 with STING which results in a block of STING-
TBK1 interaction thereby inhibiting TBK1 activation required for type I IFN production. 
From a broad perspective, the negative regulatory impact of NLRX1 is not limited to innate 
immunity elicited by HIV-1 DNA, but is extended to those caused by inflammatory DNA, 
cyclic dinucleotide, and DNA viruses that are reliant on the cGAS-STING-TBK1 pathway. 
Importantly, NLRX1 also attenuates DNA virus-induced innate immune response in mouse 
models of infection, supporting the physiologic importance of these findings.
NLRX1 has been previously found to inhibit RIG-I-MAVS and TRAF-IKK signaling (Allen 
et al., 2011; Moore et al., 2008; Xia et al., 2011), but promote ROS induction (Abdul-Sater 
et al., 2010; Tattoli et al., 2008), and autophagy (Lei et al., 2012). However, its impact on 
IFN caused by RNA viruses is not uniformly observed (Soares et al., 2013). In this study, we 
found that depletion of NLRX1 inhibits HIV-1 infection. This may be due to two 
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possibilities: by a direct alteration of anti-viral IFNs or cytokines that are secreted in the 
milieu or by a cell-intrinsic mechanism such as altered autophagy. Autophagy has been 
shown to intersect with HIV-1 biosynthesis and regulates viral yield in macrophages (Kyei et 
al., 2009). The experiment employing a transwell system favors the former possibility and 
supports the importance of secreted soluble factors that are negatively regulated by NLRX1 
in HIV-1 infection. The targeted usage of anti-IFNR antibody directly points to IFN-I as a 
soluble factor that is negatively impacted by NLRX1, resulting in increased HIV-1 infection.
This report shows the association of NLRX1 with STING which disrupts STING-TBK1 
interaction. NLRX1 resides in mitochondrial outer membrane and STING preferentially 
localizes to the ER membrane (Ishikawa and Barber, 2008; Moore et al., 2008). The 
interaction between mitochondrial proteins with ER proteins to regulate inflammation, 
calcium transfer, and autophagy has been described by others (Marchi et al., 2014). For 
example, STING is known to interact with the mitochondrial outer membrane protein MAVS 
at mitochondria-associated membranes, contributing to RNA triggered RIG-I-MAVS 
signaling pathway (Ishikawa and Barber, 2008; Zhong et al., 2008). Our finding shows that 
NLRX1 directly interacts with STING as demonstrated by using recombinant proteins. A 
further analysis of MAM-enriched fractions suggests that NLRX1 associates with STING at 
MAM.
In addition to NLRX1, we previously showed that another NLR protein, NLRC3, binds to 
both STING and TBK1 thus blocking their association and subsequent activation (Zhang et 
al., 2014). In this regard, NLRX1 functions similarly to NLRC3 by regulating STING-
dependent pathways. It is possible that NLRC3 and NLRX1 function synergistically in 
regulating cytosolic DNA triggered innate immune response delivered by HIV-1 or DNA 
viruses. It will be worthwhile to generate mice lacking both Nlrc3 and Nlrx1 or human cells 
missing both genes to test this hypothesis. Similar to NLRC3, NLRX1 interacts with STING 
through its NBD domain. Thus NBD is emerging as a common protein interacting domain 
since the inflammasome NLRC4 also relies on the NBD domain for its binding to NAIP2 
(Hu et al., 2015; Zhang et al., 2015).
NLRX1 inhibits HIV-1 mediated innate immune response and promotes HIV-1 infection in 
myeloid cells, however future studies will be necessary to assess if NLRX1 promotes HIV-1 
transmission or pathogenesis in a chronic infection. However, a recent study showed that 
HIV-1 elite controllers possess an enhanced cGAS-dependent innate responses to HIV-1, and 
a corresponding proliferation of CD8+ T cells (Martin-Gayo et al., 2015). HIV-1 triggered 
systematic inflammation is known to cause T cell exhaustion, CD4 T cells depletion, and 
immune deficiency, while adequately inhibiting IFN-I improves anti-viral T cell function 
during chronic infection (Li et al., 2014; Wilson et al., 2013). Thus NLRX1 may benefit the 
host by preventing T cell exhaustion and deficiency in chronic infection. Furthermore, 
activation of NF-κB has been reported to result in viral reactivation while NLRX1 is known 
to inhibit NF-κB activity (Allen et al., 2011; Kauder et al., 2009; Xia et al., 2011). Thus, it is 
possible that NLRX1 may restrict reactivation of HIV from latency. However, in the case of 
HSV-1 acute infection in mice, our study clearly shows that blocking NLRX1 expression can 
be beneficial to the host.
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In summary, NLRX1 is found to serve as a checkpoint of STING activation by HIV-1, DNA 
viruses, cGAMP and dsDNA. As a consequence, it acts as a host protein that is adopted by 
HIV-1 and HSV-1 to restrict innate immunity. Taken together, targeting NLRX1 may 
represent an approach to enhance early host immunity mediated by IFN to restrict these 
viruses, as well as an adjuvant strategy to enhance the efficacy of vaccines (Towers and 
Noursadeghi, 2014).
EXPERIMENTAL PROCEDURES
Experimental animals and in vivo virus infection
The C57BL/6 Nlrx1−/− mice have been described (Allen et al., 2011). Age and sex matched 
C57BL/6 littermates were produced and used in all the experiments. Mice were treated in 
accordance with the National Institute of Health Guide for the Care and Use of Laboratory 
Animals and the Institutional Animal Care and Use Committee of the University of North 
Carolina at Chapel Hill. Eight weeks old mice were infected with HSV with 2×107 or 5×107 
pfu of viruses per mouse by intravenous injection or 2×107 pfu of viruses per mouse by 
intraperitoneal injection. The body weight of the mice was monitored accordingly. For 
cytokine studies, mice were sacrificed 6 hours post-infection and sera were collected 
through cardiac puncture. For HSV-1 genome copy number and viral titer measurement, 
brains were harvested 5 days post-infection.
Cell stimulation and virus infection
MEFs, BMDM, or peritoneal macrophages were seeded in 24-well plates and transfected 
with 2 g/ml of ISD, VACV 70-mer, c-di-GMP, or cGAMP by lipofectamine 2000 
(ThermoFisher Scientific). BMDMs were infected with HSV-1 (KOS strain) at the indicated 
multiplicity of infection (MOI) at 37 °C for 1 hr. MEFs were infected with HSV-1 or 
vaccinia virus at MOI of 1 or 5 at 37 °C for 1 hr. Cells were then washed with warm PBS 
and cultured in complete DMEM.
siRNA transfection
Transient knockdown of human NLRX1 was achieved by transfection of specific siRNAs 
(si-NLRX1-1; Qiagen (siNOD9_4; SI00659960), si-NLRX1-2; Qiagen (siNLRX1_2; 
SI04231255), si-NLRX1-3; Qiagen (siNOD9_5; SI03143952)) or unspecific negative 
control siRNA (si-scramble, target sequence: 5′-AAGGTAATTGCGCGTGCAACT-3′). 
siRNAs were transfected using Lipofectamine RNAiMAX Reagent (Invitrogen) for 
HEK293T cells or Stemfect RNA Transfection Kit (Stemgent) for MDMs and MDDCs 
following the manufacturer’s instructions. Briefly, 293T cells were reverse transfected using 
1.5 pmol siRNA and 0.15 μl RNAiMAX reagent per 96-well. MDMs and MDDCs were 
transfected on day 5 of differentiation after batch lift and seeding in 96-well format using 2.5 
pmol siRNA and 0.136 μl stemfect reagent.
HIV-1 propagation and infection
The single round virus pNL4.3-Luc E-R+ (HIV-1 wild-type deltaEnv, encoding firefly 
luciferase GL3, kind gift of Nathaniel Landau) was pseudotyped with VSV-G (HIV-VSV). 
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Viruses were produced as described previously (Konig et al., 2008). HIV-1 R3A virus was 
amplified in SupT1 cells as described previously (Guo et al., 2014).
MDMs and MDDCs were infected with HIV-VSV at a MOI of 0.25 or 0.5. MEFs and 
BMDMs were infected with HIV-VSV at a MOI of 1 for 6 hr followed by culture in 
complete DMEM. THP-1 cells were infected with HIV-VSV at a MOI of 1 by spinoculation 
(1,000 × g, 25 °C) for 3 hr and cultured in completed RPMI medium. Infection readout was 
performed 24, 48, and 72 hr post-infection by luciferase assay.
Real time PCR analysis of HIV-1 reverse transcripts
THP-1 cells containing scrambled shRNA or shRNA for NLRX1 were infected with HIV-
VSV at a MOI of 1 by spinoculation (1,000 × g, 25 °C) for 3 hr and cultured in completed 
RPMI medium. Total DNA was extracted 3, 6, 9, 12, 24 hpi and HIV-1 reverse transcripts 
were quantified by real time PCR as previous described (Mbisa et al., 2009).
Statistical Analysis
Statistical analysis was carried out with Prism 5.0. All data are shown as or mean ± standard 
error of the mean (SEM). The mean values for biochemical data from each group were 
compared by Student’s t-test or Mann-Whitney U test. Comparisons between multiple time 
points were analyzed by repeated-measurements analysis of variance (ANOVA) with 
Bonferroni post-tests. In all tests, P-values of less than 0.05 were considered statistically 
significant. *P< 0.05, **P<0.01, ***P<0.001.
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Highlights
• NLRX1 inhibits HIV-1 cDNA-induced innate immune response and enhances 
HIV-1 infection
• NLRX1 interacts with the DNA sensing adaptor STING to disrupt STING-
TBK1 signaling
• STING deficiency abrogates the enhancement of HIV-1 infection by NLRX1
• Nlrx1−/− mice show enhanced innate immunity and are more resistant to DNA 
viruses
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Figure 1. NLRX1 is required for HIV-1 infection
(A) Scheme of unbiased screening of host factors required for HIV-1 infection which 
identified that siRNA targeting NLRX1 reduced HIV-1 infection.
(B) Knockdown of NLRX1 in THP-1 cells by shRNA (left) or CRISPR-Cas9/sgRNA 
(right).
(C-E) THP-1 cells with scrambled or shRNA or sgRNA targeting NLRX1 were infected 
with a single-cycle luciferase reporter virus pseudo-typed with a pH-dependent envelope 
VSV-G (HIV-VSV). After 24, 48, and 72 hours, luciferase activity (C) and the expression of 
HIV-1 Gag p55 protein (D) were determined. Densitometry analysis was performed for Gag 
p55 levels shown in panel D (E). SC: scrambled control, sh-1: sh-NLRX1-1, sh-2, sh-
NLRX1-2, sg-1: sg-NLRX1-1, sg-2: sg-NLRX1-2.
(F and G) Knockdown of NLRX1 decreases HIV-1 infection in human primary macrophages 
(F) and dendritic cells (G). Monocyte derived macrophage and monocyte derived dendritic 
cells were transfected with scrambled siRNA or siRNA targeting NLRX1 followed by 
infection with HIV-VSV. HIV-1 infection as reflected by luciferase activity is shown. Data 
pooled from three or four different donors.
(H) Same as C except that the infection was done by using a CCR5/CXCR4 dual tropic 
HIV-1 strain R3A. HIV-1 particle release was quantified by p24 ELISA.
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(I) Real-Time PCR analysis of HIV-1 reverse transcription and cDNA nuclear import as 
previously described (Mbisa et al., 2009). THP-1 cells with scrambled or shRNA or sgRNA 
targeting NLRX1 were infected with a HIV-VSV. At indicated time points, total DNA was 
extracted and HIV-1 DNA was quantified by amplifying indicated target sequences.
Data are presented as the mean ± standard error of the mean (SEM). *p < 0.05, **p < 0.01, 
***p < 0.001, ****p < 0.0001 (Student’s t test). All data are representative of two or three 
independent experiments.
See also Figure S1.
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Figure 2. Removal of NLRX1 enhances innate immune response upon HIV-1 infection
(A) THP-1 cells with shNLRX1 or scrambled control shRNA were infected with HIV-VSV 
(MOI=1) and the induction of IFNβ was determined over time. IFNB1 and MX2 mRNA 
levels were determined by qPCR 18 hpi.
(B) WT or Nlrx1−/− BMDM were infected with HIV-VSV (MOI=1), at different time points, 
IFNβ was measured by ELISA and Il6, Isg15 and Rantes were measured by qPCR.
(C) WT or Nlrx1−/− MEF were infected with HIV-VSV, MOI=1, at different time points. 
Ifnb was measured by qPCR and ELISA and Il6, Tnf, Isg15 and Rantes were measured by 
qPCR.
(D) THP-1 cells with shNLRX1 or scrambled control shRNA were infected with HIV-VSV 
(MOI=1) in the presence of anti-IFNR1 or control IgG. At 72 hpi, luciferase activity 
(normalized by total protein) was determined to measure virus infection (left panel). 
Luciferase data were normalized by setting scrambled control as 1 (right panel).
(E) THP-1 cells with shNLRX1 (X1 KD) or scrambled control (Scr) shRNA were infected 
with HIV-VSV, MOI=1, and seeded in the plate with transwell as indicated, and luciferase 
activity from upper and lower wells was determined for virus infection 72 hpi. Luciferase 
activity was normalized by total protein.
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(F) THP-1 cells with shNLRX1 or scrambled control shRNA were infected with HIV-VSV, 
MOI=1. 1 day after infection, cells were collected and p-TBK1, p-IKKε, p-IRF3, p-STAT1, 
TBK-1, IKKε, IRF3, STAT1, and STING were determined by western blot. GAPDH was 
used as the loading control.
Data are presented as the mean ± standard error of the mean (SEM). *p < 0.05, **p < 0.01 
(Student’s t test). All data are representative of at least three independent experiments.
See also Figure S2.
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Figure 3. NLRX1 inhibits STING-dependent DNA sensing pathway
(A-C) HEK293T cells were transfected with the ISRE promoter reporter with the internal 
control Renilla luciferase reporter pLR-TK. Either empty vector or NLRX1 expression 
plasmid was transfected. STING (A), TBK1 (B) or IRF3 (C) was used as activator of ISRE 
reporter as indicated. Luciferase assays were performed 24 hr after transfection.
(D) Same as (A), except cells were transfected with either an empty plasmid or with 
NLRX1, NLRP3, NLRP11, NLRC5 or NOD2 expression plasmid.
(E-G) WT and Nlrx1−/− MEFs were transfected with ISD (E), cGAMP (F), or c-di-GMP (G) 
respectively. Ifnb, Il-6, and Tnf-α transcripts and IFNβ were measured 6 hr after transfection 
as indicated.
(H) Immunoblot of phosphorylated (p-) TBK1, TBK1, STING, and NLRX1 in lysates of 
WT and Nlrx1−/− MEFs transfected with cGAMP for indicated time points. β-actin was used 
as the loading control. Densitometry analysis was performed for (p-) TBK1 levels by 
normalizing to TBK1.
(I) WT and Nlrx1−/− BMDMs were transfected by ISD, VACV 70-mer, or cGAMP. IFNβ 
and Ifna4 transcript were measured 3 hr after transfection.
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(J) Peritoneal macrophages isolated from WT and NLRX1−/− mice were transfected with 
ISD, VACV 70-mer, or c-di-GMP, respectively. IFNβ was assessed 4 hr after transfection.
Data are presented as the mean ± standard error of the mean (SEM). *p < 0.05, **p < 0.01 
(Student’s t test). All data are representative of at least three independent experiments.
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Figure 4. NLRX1 disrupts STING-TBK1 interaction
(A) Association of over-expressed NLRX1 and STING (left) and of overexpressed STING 
and TBK1 (right) in HEK293T cells. FLAG-NLRX1 and HA-STING was singly expressed 
or co-expressed in HEK293T cells. Co-immunoprecipitaion was performed with anti-FLAG 
beads or anti-HA beads respectively. Similarly, FLAG-TBK1 and HA-STING was singly 
expressed or co-expressed in HEK293T cells. Co-immunoprecipitaion was performed with 
anti-FLAG beads or anti-HA beads respectively.
(B) Determination of endogenous NLRX1-STING association in THP-1 cells with 
scrambled sgRNA (sg-Scr) or sgRNA for NLRX1 (sg-NLRX1). Immunoprecipitation was 
performed by using anti-NLRX1, anti-STING or control IgG.
(C) Determination of endogenous NLRX1-STING association in primary MEF. 
Immunoprecipitation was performed by using anti-NLRX1 or control IgG.
(D and E) Recombinant NLRX1 and STING in vitro binding assay was performed by using 
antibodies against STING (D) and NLRX1 (E). Immunoblots were performed with the 
antibodies indicated.
(F) Mapping of NLRX1 domains involved in interaction with STING. FLAG tagged full 
length NLRX1, NLRX1 lacking X domain (NBD+LRR), NLRX1 LRR, NLRX1 lacking 
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LRR domain (X+NBD), and NLRX1 NBD was expressed in the absence or presence of HA-
STING in HEK293T cells. Immunoprecipitation was performed by anti-HA beads.
(G) Partial co-localization of NLRX1 and STING. FLAG-NLRX1 and HA-STING was co-
expressed in HEK293T cells and immunofluorescence staining was performed. Pictures 
were taken using confocal microscopy. Scale bar equals to 20 μm.
(H) Determination of endogenous NLRX1-STING association in MAMs isolated from 
human foreskin fibroblast (HFF) cells. Immunoprecipitation was performed by using anti-
NLRX1 or control IgG. Sig1R was used as the MAMs marker.
(I) NLRX1 attenuates STING-TBK1 interaction. STING and TBK1 were co-expressed in 
HEK293T cells with increasing dose of NLRX1. Immunoprecipitation was performed with 
anti-HA beads.
All data are representative of at least three independent experiments.
See also Figure S3-S7.
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Figure 5. Nlrx1 deficiency causes enhanced innate immune response to DNA virus infection
(A and B) WT and Nlrx1−/− MEFs were infected with vaccinia virus (VACA) (MOI=1 or 5), 
Ifnb transcript (E) and MCP-1 (F) were assessed.
(C-F) WT and Nlrx1−/− MEFs were infected with HSV-1 (MOI=0.1 or 1), Ifnb transcript 
(C), IL-6 (D), MCP-1 (E), and IP-10 (F) were assessed.
(G) Immunoblot of phosphorylated (p-) TBK1, TBK1, (p-) STAT1, (p-) p65, STING, and 
NLRX1 in lysates of WT and Nlrx1−/− BMDMs infected with HSV-1 (MOI=1) for indicated 
time points. β-actin was used as the loading control.
(H) WT or Nlrx1−/− BMDMs were infected with HSV-1 (MOI=0.1) and HSV-1 genome 
copies were quantified by qPCR 24 hr post infection.
Data are presented as the mean ± standard error of the mean (SEM). *p < 0.05, **p < 0.01 
(Student’s t test).
Data in A-F are from one experiment and data in G and H are representative of at least three 
independent experiments.
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Figure 6. NLRX1 promotes HIV-1 infection in a STING-dependent manner
(A) NLRX1 and STING expression were attenuated by transducing THP-1 cells with 
lentivirus expressing shRNA for NLRX1 and Cas9 nuclease plus sgRNA targeting STING. 
Attenuation of NLRX1 and STING expression were confirmed by immunoblot.
(B) THP-1 cells containing scrambled shRNA, shRNA for NLRX1, or both shRNA for 
NLRX1 and sgRNA for STING were infected with HIV-VSV, MOI=1, luciferase activity 
was determined 2 and 3 dpi. Fold differences between indicated groups were labeled on top 
of each group.
(C and D). Same as (B) except that IFNB1 (C) and MX2 (D) mRNA levels were determined 
by qPCR 16 hpi.
Data for luciferase and qPCR are presented as the mean ± standard error of the mean (SEM). 
*p < 0.05, **p < 0.01 (Student’s t test).
Data are representative of at least three independent experiments.
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Figure 7. Nlrx1 deficient mice are more resistant to HSV-1 infection
(A) WT and Nlrx1−/− mice were infected i.p. with HSV-1 (2×107 pfu) and body weight was 
monitored.
(B-G) WT and Nlrx1−/− mice were infected i.v. with HSV-1. Body weight (B), percentage of 
survival (C), HSV-1 genomic DNA copies (D), viral titers in the brain (E), IFNβ (F) and IL-6 
(G) in the serum were assessed. In B, D, E, F and G, the dose of infection is 2×107 pfu/
mouse and in C, the dose of infection is 5×107 pfu/mouse. *p < 0.05 (Student’s t test or 
Mann-Whitney U test). Data are representative of at least two independent experiments.
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